ArticleBritish journal of clinical pharmacology2021

The potential of individualized dosing of ravulizumab to improve patient-friendliness of paroxysmal nocturnal haemoglobinuria treatment at reduced costs.

Mendy Ter Avest et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.